COGT vs KO · $5.75B cap vs P/E 25, rev $47.94B
Cogent Biosciences Inc (COGT) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
COGT does not have a complete income-statement cache yet.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
COGT currently screens at market cap $5.75B. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the COGT and KO stock pages for the full models.
Not investment advice.